{"schema_version":"secwatch.filing_event.v1","accession":"0001274737-21-000085","form_type":"8-K","ticker":"XGN","cik":"0001274737","company_name":"EXAGEN INC.","filed_at":"2021-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.476129+00:00","generated_at":"2026-06-30T00:16:30.766585+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Exagen appoints Ana Hooker to board of directors; she is SVP Operations at Exact Sciences","bullets":["Board increased from 8 to 9 members; appointment effective July 29, 2021.","Hooker receives option to purchase 15,000 shares, vesting over 3 years monthly, plus cash compensation per non-employee director plan.","Hooker is SVP Operations at Exact Sciences since 2015; previously 15 years at ARUP Laboratories.","Board determined Hooker is independent under Nasdaq listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001274737-21-000085","json":"https://secwatch.observer/filing/0001274737-21-000085.json","markdown":"https://secwatch.observer/filing/0001274737-21-000085.md","text":"https://secwatch.observer/filing/0001274737-21-000085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/0001274737-21-000085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/xgnxdirectorappointment7x2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T00:16:30.766585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f10e2dc927","claim":"Ana Hooker was appointed as Director at EXAGEN INC..","evidence_excerpt":"the Board approved an increase in its authorized size from eight members to nine members and appointed Ana Hooker to fill the vacancy created by such increase and serve as a Class II director, with an initial term expiring at the Company's 2024 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000085/0001274737-21-000085-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}